The Impact of Self-Managed Virtual Reality Relaxation on Non-invasive Ambulatory Physiological Markers in Home-Based Psychiatric Care.
Lisanne M Robbemond, Catheleine M G van Driel, Niek Scholten...
https://pubmed.ncbi.nlm.nih.gov/42406301/Actively Recruiting
Led by University Medical Center Groningen · Updated on 2025-03-30
171
Participants Needed
5
Research Sites
52 weeks
Total Duration
This research aims to study the effects of a virtual reality tool called VRelax on stress and sleep problems in people treated for burn-out, anxiety, mood, or psychotic disorders. Stress and sleep disturbances are known to worsen mental health symptoms in these conditions. The study will compare VRelax plus usual treatment to usual treatment with relaxation exercises, focusing on recovery, social functioning, healthcare use, and costs over short, medium, and long terms. Participants will be randomly assigned to use either VRelax, which offers immersive 360-degree nature videos with interactive elements for stress reduction, or audio-guided relaxation exercises like breathing and muscle relaxation. Both groups will continue their usual treatment. They are instructed to use their assigned relaxation method for at least 20 minutes a day, five days a week, over six weeks. The first and last weeks of this period include wearing devices to monitor heart rate, skin conductance, and sleep. During the study, participants will complete assessments at the start, six weeks, 26 weeks, and 52 weeks to measure symptoms, quality of life, depression, anxiety, stress, sleep, and physiological markers such as blood pressure and blood tests. Questionnaires and wearable devices help track changes in stress, mood, and sleep. The main measure is change in symptoms after six weeks. Safety and usability of VRelax are also monitored throughout the trial, which lasts one year from the first assessment.
CONDITIONS
Self-management of Stress and Sleep Disturbances with Virtual Reality Relaxation
L
Lisanne Robbemond, MSc
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
University Medical Center Groningen
Lead Sponsor
University of Twente
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person) for consent and eligibility assessment
Duration - 2 weeks
Participants complete physical and physiological assessments and fill out multiple questionnaires. They receive wearables to monitor heart rate and sleep for two weeks and instructions for the intervention.
1 baseline visit (in-person) plus wearable monitoring at home for 2 weeks
Duration - 6 weeks
Participants use either Virtual Reality relaxation (VRelax) or relaxation exercises for at least 20 minutes a day, five days a week, for six weeks while wearing wearables during the first and last week.
Wearable monitoring during first and last week of treatment; daily use of assigned relaxation method
Duration - 1 visit
Participants repeat the baseline assessments including physical and physiological tests and questionnaires, plus usability assessment for those using VRelax.
1 visit (in-person)
Duration - Approximately 1 year
Participants complete questionnaires to assess symptoms, quality of life, and other health measures at 26 and 52 weeks after baseline.
2 visits (in-person) at 26 weeks and 52 weeks post-baseline
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Lisanne M Robbemond, Catheleine M G van Driel, Niek Scholten...
https://pubmed.ncbi.nlm.nih.gov/42406301/University Medical Center Groningen
Lead Sponsor
University of Twente
Collaborating Sponsor